Fred Saad
Université de Montréal
H-index: 150
North America-Canada
Top articles of Fred Saad
Artificial intelligence unravels interpretable malignancy grades of prostate cancer on histology images
npj Imaging
2024/3/6
Survival benefit of nephroureterectomy in systemic therapy exposed metastatic upper tract urinary urothelial carcinoma patients
European Urology
2024
CONTACT-2: Phase 3 study of cabozantinib (C) plus atezolizumab (A) vs second novel hormonal therapy (NHT) in patients (pts) with metastatic castration-resistant prostate cancer …
2024/2/1
Fred Saad
H-Index: 93
PD23-09 THE EFFECT OF ADRENALECTOMY ON OVERALL SURVIVAL IN METASTATIC ADRENOCORTICAL CARCINOMA
The Journal of Urology
2024/5
Fred Saad
H-Index: 93
Multivariable model versus AJCC staging system: cancer-specific survival predictions in adrenocortical carcinoma
Endocrine-Related Cancer
2024/4/1
Fred Saad
H-Index: 93
Corrigendum to “Impact of Concomitant Prostate Cancer Medications on Efficacy and Safety of Relugolix Versus Leuprolide in Men With Advanced Prostate Cancer”[Clinical …
Clinical Genitourinary Cancer
2024
Differences in other-cause mortality in metastatic renal cell carcinoma according to partial vs. radical nephrectomy
Surgical Oncology
2024/2/13
Fred Saad
H-Index: 93
Contemporary sex-specific analysis of the association of marital status with cancer-specific mortality in primary urethral carcinoma patients
Urologic Oncology: Seminars and Original Investigations
2024/2/1
Fred Saad
H-Index: 93
The Effect of Treatment Intensification on Other-Cause Mortality in Clear-Cell Metastatic Renal Cell Carcinoma Patients
Clinical Genitourinary Cancer
2024/4/1
Fred Saad
H-Index: 93
Efficacy and safety of darolutamide in combination with androgen-deprivation therapy and docetaxel in European patients from the phase 3 ARASENS trial
The Oncologist
2024/3/1
MP22-07 CONTEMPORARY CONDITIONAL CANCER-SPECIFIC SURVIVAL RATES IN SURGICALLY TREATED NON-METASTATIC PRIMARY URETHRAL CARCINOMA
The Journal of Urology
2024/5
Fred Saad
H-Index: 93
Charles Brenton Huggins: A historical review of the Nobel laureate’s pioneering discoveries
Cancer
2024/4/1
Fred Saad
H-Index: 93
PD23-06 SURVIVAL DIFFERENCES BETWEEN PHEOCHROMOCYTOMA AND PARAGANGLIOMA PATIENTS
The Journal of Urology
2024/5
Fred Saad
H-Index: 93
Other-Cause Mortality, According to Partial vs. Radical Nephrectomy: Age and Stage Analyses
Clinical Genitourinary Cancer
2024/4/1
Fred Saad
H-Index: 93
The European network for the study of adrenal tumors staging system (2015): A North American validation
The Journal of Clinical Endocrinology & Metabolism
2024/1/24
Matteo Ferro
H-Index: 6
Fred Saad
H-Index: 93
Olaparib plus abiraterone for metastatic castration-resistant prostate cancer: pharmacokinetics data from the PROpel trial
European Urology Oncology
2024/4/1
Omar Din
H-Index: 5
Fred Saad
H-Index: 93
Contemporary validation of cT1a vs. cT1b substaging of incidental prostate cancer
World Journal of Urology
2024/4/28
Fred Saad
H-Index: 93
LONGITUDINAL CHANGES IN PATIENT-REPORTED OUTCOMES (PROs) IN PATIENTS WITH HIGH-RISK BIOCHEMICALLY RECURRENT (BCR) NONMETASTATIC CASTRATION-SENSITIVE PROSTATE CANCER (NMCSPC …
Urologic Oncology: Seminars and Original Investigations
2024/3/1
Efficacy of olaparib (O) plus abiraterone (A) versus placebo (P) plus A in patients (pts) with metastatic castration-resistant prostate cancer (mCRPC) with single homologous …
2024/2/1
Patient reported outcomes (PROs) among patients with metastatic castration-resistant prostate cancer (mCRPC) by homologous recombination repair mutations (HRRm) gene clusters …
Blood
2023/11/28
Co-Authors
